Swiss Semiconductors Stock News

Novartis (SWX:NOVN) is back in focus after the US Food and Drug Administration approved an expanded use of Pluvicto in combination with androgen receptor pathway inhibitors for PSMA-positive metastatic hormone-sensitive prostate cancer. See our latest analysis for Novartis. Novartis shares have been firming over 2026, with a 16.68% year to date share price return and a 38.50% total shareholder return over one year, as investors weigh the expanded Pluvicto approval alongside recent earnings,...

Investors in Zehnder Group AG ( VTX:ZEHN ) had a good week, as its shares rose 8.3% to close at CHF67.70 following the...

Clariant came into this earnings print trading at CHF9.15 after a strong run over the past month, yet the latest half-year numbers still tell a turnaround story in progress rather than one already secured. The stock looks inexpensive on simple sales multiples, but the headline from H1 2026 is that profitability remains fragile. Group EBITDA before exceptionals held at a mid to high teens margin, while the company remained loss making over the last twelve months and net debt edged higher to...

Interroll Holding stock has been treading water in recent weeks, with a small gain of just over 3% in the past month and a double digit slide over the past quarter. The earnings headline that cuts through the noise is margin pressure. First half 2026 delivered a 10% EBIT margin and net profit of CHF 19.8m, slightly softer despite solid intralogistics demand. The market sees a high quality balance sheet, a trailing P/E of 20.2x and analyst forecasts that point to faster earnings growth than...

Holcim stock closed at CHF73.34 on the day of the results and has drifted slightly lower over the past week. The market reaction looks muted for a company that just reported mid single digit organic net sales growth and double digit organic recurring EBIT growth in the first half. The real story is not today’s small move in the share price. It is how investors weigh that earnings power against a P/E above 100x that is anchored in a year affected by a CHF1.3b one off loss. Is Holcim a genuine...

Zehnder Group stock closed at CHF67.70 on Friday after a steady run over the past month. Yet the real story sits in the income statement rather than the ticker. The latest half year numbers put a bright spotlight on profitability. Net profit margin now stands at 6% compared with 2.4% a year earlier and earnings over the past 12 months are sharply higher. That kind of margin rebuild matters more than a single day’s move. For long term investors in building ventilation and climate systems, the...

Bucher Industries stock closed at CHF316 after a choppy week that left shares down about 4.5% over seven days, even as the latest half year numbers landed. The market focused on softer profit metrics more than the headline revenue figure of CHF1,471.4m for H1 2026. Net income of CHF87.5m and basic earnings per share of CHF8.90 point to a profit squeeze that matters far more than a single day price move. For long term holders, the key question now is how this margin pressure fits with the...

Sika AG ( VTX:SIKA ) investors will be delighted, with the company turning in some strong numbers with its latest...

Investors signalled that they were pleased with Roche Holding AG's ( VTX:ROP ) most recent earnings report. According...

Shareholders might have noticed that Logitech International S.A. ( VTX:LOGN ) filed its quarterly result this time last...

Ascom Holding came into this earnings day with a stock that had drifted, down around 11% over the past month and slightly weaker over the past week, while trading on a single digit P/E multiple. The H1 2026 numbers did not bring a flashy revenue surge, but they did show what matters most here. Profitability is quietly tightening, with basic earnings per share at CHF0.16 for the half and trailing net profit margin at 6.3%. The key point is that profit quality is improving while the market...

Autoneum Holding stock closed at CHF130.40 on 30 July, capping a strong run over the past month. Yet the real story in these H1 2026 results is not the share price. It is how a relatively low P/E of 12.3x sits beside a double digit trailing twelve month earnings per share of CHF10.60. For short term traders, the move has already happened. For longer term holders, the key question now is how to weigh that earnings power and modest 2.7% net profit margin against high debt and an uneven dividend...

Sika (SWX:SIKA) drew fresh attention after its half year 2026 results, which showed broadly steady sales and earnings in Swiss francs, along with an upgrade to full year local currency sales guidance. See our latest analysis for Sika. The recent half year 2026 update seems to have shifted sentiment around Sika, with the stock showing a 7 day share price return of 13.86% and a 90 day share price return of 24.88%. However, the 1 year total shareholder return is down 6.31% and the 5 year total...

Roche Holding (SWX:ROP) received FDA 510(k) clearance for its cobas BV/CV molecular diagnostic assay, expanding its sexual health testing portfolio in the United States. The assay is designed to support more accurate diagnosis of bacterial vaginosis and vulvovaginal candidiasis, two common women's health conditions that are often misdiagnosed. The EMA’s Committee for Medicinal Products for Human Use issued a positive opinion for Susvimo, a ranibizumab implant for neovascular age related...

Schindler Holding (SWX:SCHN) reaffirmed its 2026 earnings guidance and released half-year results, giving investors fresh detail on how Modernization, Service and New Installations are shaping the company’s revenue profile this year. See our latest analysis for Schindler Holding. The reaffirmed guidance and higher earnings come against a mixed share price picture for Schindler Holding, with the stock down 12.11% on a year-to-date share price return and the 1-year total shareholder return also...

UBS has just put fresh attention on capital markets and investment banking after reporting Q2 pre tax profits of US$3.6b, up 64% year on year, alongside a new US$3b share buyback. The CEO also called the recent AI pullback a healthy correction and pointed to strong M&A and IPO activity, even as geopolitical risks linger. For investors, that mix of solid earnings, active deal flow and an AI reset could be significant. This article walks through 3 stocks exposed to those same news drivers and...

Nestlé SA recently announced a plan to create Peranel, a 50:50 joint venture with Platinum Equity for its waters and premium beverages business, valuing the new company at about €4.90 billion and implying roughly €3.00 billion in cash proceeds for Nestlé when the deal closes, while also reporting half‑year 2026 sales of CHF43,109 million and net income of CHF3,472 million, both lower than a year earlier. The joint venture carves out more than 30 water and premium beverage brands into a...

Investors in SGS SA ( VTX:SGSN ) had a good week, as its shares rose 2.5% to close at CHF96.34 following the release of...

It's been a pretty great week for Schweiter Technologies AG ( VTX:SWTQ ) shareholders, with its shares surging 14% to...

Investors were disappointed by The Swatch Group AG's ( VTX:UHR ) latest earnings release. We did some further digging...

Why the new retina training centre matters for Alcon stock Alcon (SWX:ALC) is in focus after launching the Aravind Alcon Global Centre of Excellence for Vitreoretinal Surgery Training in Coimbatore, a new retina focused training hub within Aravind Eye Care System. See our latest analysis for Alcon. The retina training centre launch fits into a mixed year for Alcon, with the share price at CHF56.5, a small 1 month share price gain of 2.36% but a year to date share price decline of 11.08%,...

The market has treated Sulzer gently in recent weeks, with the stock up around 11.6% over the past month and closing at CHF152.3 on the day of the H1 2026 release. The headline from the numbers is not revenue growth; it is margin power. Sulzer lifted its reported EBITDA margin to about 15.5% in the first half while holding sales broadly steady. That mix of flattish top line and firmer profitability puts emotion to the test. Today’s price action looks like a debate over whether a margin driven...

Siegfried Holding (SWX:SFZN) has drawn investor attention after appointing Eduardo Montanha as Chief Operating Officer, consolidating oversight of Drug Substances and Drug Products into a single leadership role. See our latest analysis for Siegfried Holding. At a share price of CHF72.85, Siegfried Holding has seen a 1 month share price return of 4.07%, while the 1 year total shareholder return is down 22.43%. This suggests that recent momentum contrasts with weaker longer term results as...

The European market has recently shown resilience, with the pan-European STOXX Europe 600 Index posting gains amid robust corporate earnings and geopolitical tensions. In this environment, dividend stocks can offer a stable income stream, making them an attractive option for investors seeking to navigate market volatility while benefiting from potential capital appreciation.